Early research (Phase 1)Study completedNCT00112229What this trial is testingImmunotherapy of HLA-A2 Positive Stage III/IV Melanoma PatientsWho this might be right forMelanoma Centre Hospitalier Universitaire Vaudois 29
Testing effectiveness (Phase 2)Study completedNCT01321437What this trial is testingStudy of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant MelanomaWho this might be right forMelanomaMalignant MelanomaStage IIIA Melanoma+2 more University of California, Irvine 11
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Not applicableUnknownNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 210
Testing effectiveness (Phase 2)UnknownNCT05767879What this trial is testing(Neo)Adjuvant BRAF/MEK Inhibition in pN1c MelanomaWho this might be right forMelanoma Stage IIIIn-Transit Metastasis of Cutaneous Melanoma Leiden University Medical Center 28
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT07302607What this trial is testingPredictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021Who this might be right forStage III Melanoma University Hospital, Strasbourg, France 221
Testing effectiveness (Phase 2)Study completedNCT04570332What this trial is testingBO-112 With Pembrolizumab in Unresectable Malignant MelanomaWho this might be right forMelanoma Highlight Therapeutics 42
Large-scale testing (Phase 3)UnknownNCT00052130What this trial is testingVaccine Therapy for Patients With Stage III MelanomaWho this might be right forMalignant Melanoma CancerVax Corporation 1,118
Testing effectiveness (Phase 2)Study completedNCT00669019What this trial is testingSaracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01258855What this trial is testingAldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forMetastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00005815What this trial is testingTemozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02304458What this trial is testingNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasWho this might be right forMetastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 140
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Not applicableStudy completedNCT00828126What this trial is testingPET-CT in the Management of Patients With Stage III or IV Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02965716What this trial is testingTalimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV MelanomaWho this might be right forAdvanced MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+5 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT05251389What this trial is testingFMT to Convert Response to ImmunotherapyWho this might be right forMelanoma Stage IIIMelanoma Stage IV The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78